ArticleBrain and behavior2025
Effects of Electroacupuncture on Syt3 and GluA2 in Rats With Limb Spasms After Intracerebral Hemorrhage.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
Abstract
backgroundClinical studies have confirmed that electroacupuncture (EA) has the potential to improve spasticity after intracerebral hemorrhage (ICH), yet its precise mechanism remains unclear. Synaptotagmin-3 (SYT-3), by mediating the internalization of the glutamate AMPA receptor GLUA2, may be related to EA's mechanism. This study aims to explore the mechanism by which EA improves limb spasticity after ICH, providing scientific evidence for its clinical application.
methodsICH models were established using stereotaxic injection of autologous tail blood into the right striatum. SD rats were randomly divided into Sham, ICH, ICH + SCRAMBLE, EA, and ICH + TAT-GLUA2-3Y groups. Rats in the EA group received 30 min of EA treatment daily after ICH. Muscle tone, neurological deficits, and motor function were assessed. After 3 and 7 days of intervention, the motor cortex was dissected for Western blot analysis of SYT-3, GLUA2, and P-GLUA2-Ser880 expression. Immunoprecipitation was used to detect the interaction between SYT-3 and GLUA2. Nissl staining and NeuN staining were employed to evaluate brain damage. Fluorescence double-labeling technique was used to observe the expression of SYT-3 and GLUA2 in the cell membrane and cytoplasm. Transmission electron microscopy was utilized to examine the microstructure of neurons and synapses.
resultsCompared to the ICH group, rats in the EA group showed reduced muscle tone in the left limbs and significant improvement in neurological deficits and motor function. In the ICH + TAT-GLUA2-3Y group, the binding of SYT-3 and GLUA2 was inhibited, spastic symptoms were alleviated, and membrane expression of GLUA2 increased. In the EA group, SYT-3 levels were significantly reduced, GLUA2 expression increased in the membrane and cytoplasm, and P-GLUA2-Ser880 expression decreased. Rats in the EA group showed increased neuron numbers, normal mitochondrial morphology, and improved synaptic structure in Nissl staining, immunofluorescence, and transmission electron microscopy.
conclusionEA effectively improves limb spasticity following ICH by inhibiting the SYT-3/GLUA2 pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.